Skip to content

To know that the u (Urinary)CD80 to UCr ratio help identify children with nephrotic syndrome who are likely to respond well to steroid therapy

To evaluate the role of Urinary CD80 (uCD80) to Urinary Creatinine (UCr) ratio in Predicting the response to Steroids in Children with Nephrotic Syndrome ââ?¬â?? An Observational Study - NA

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/077352
Enrollment
50
Registered
2024-11-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N049- Nephrotic syndrome with unspecified morphologic changes

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr P Sailahjapriydarsini
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Children aged 1-16 years with Denovo Nephrotic syndrome 2)Patients with eGFR�30 ml /min (Calculated by using Schwartz formula).

Exclusion criteria

Exclusion criteria: 1)Patients with peptic ulcer disease and with HIV Hepatitis-B C Tuberculosis. 2)Patients who are unwilling to take glucocorticoids 3)Patients with liver dysfunction (ALT/AST more than 3 times the upper limit of normal) 4)Patients on antipsychotic medication 5)Patients with type-1 Diabetes Mellitus (RBS 200�mg/dl or 11.1mmol/L)

Design outcomes

Primary

MeasureTime frame
1)The Cut off value of Urinary CD80 to Urinary Creatinine (ucr) ratio to predict steroid responsiveness 2)Change in uCD-80/uCr ratio from baseline to end of 4 weeks Timepoint: 4weeks

Secondary

MeasureTime frame
1)Change in quality of life (PedsQL 4.0 Generic Core Scales17) score from baseline to end of 4 weeks 2)Incidence of Adverse events Timepoint: 4weeks

Countries

India

Contacts

Public ContactDr P Sailajapriyadarsini

NIMS Hyderabad

ushapingali@yahoo.com07032063248

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 28, 2026